Watchlist Price Alert

Corvus Pharmaceuticals In... (CRVS)

NASDAQ: CRVS · Real-Time Price · USD

3.62

0.04 (1.12%)

At close: May 16, 2025, 3:59 PM

3.52

-2.63%

After-hours: May 16, 2025, 05:55 PM EDT

Corvus Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	8.74M	12.62M	13.16M	63.46M	16.45M	5.15M	114.6M	90.06M	134.9M
Short-Term Investments	43.22M	14.53M	29.14M	5.99M	27.8M	72.83M	75.4M	44.95M	129.85M
Long-Term Investments	12.54M	16.12M	21.88M	34.27M	37.23M	n/a	n/a	n/a	n/a
Other Long-Term Assets	632K	89K	1.84M	2.55M	2.4M	3.34M	1.46M	2.05M	2.01M
Receivables	216K	63K	633K	539K	86K	329K	337K	132K	365K
Inventory	n/a	n/a	-735K	-667K	-492K	-815K	-602K	-852K	-1.14M
Other Current Assets	548K	220K	102K	128K	406K	486K	265K	720K	772K
Total Current Assets	54.41M	27.96M	42.3M	69.45M	44.26M	77.98M	114.6M	90.06M	134.9M
Property-Plant & Equipment	1.33M	1.39M	2.22M	3.19M	1.65M	2.33M	2.18M	2.67M	3.25M
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	14.5M	17.6M	25.94M	40M	41.27M	5.66M	3.63M	4.72M	5.25M
Total Assets	68.91M	45.55M	68.24M	109.45M	85.53M	83.65M	118.23M	94.78M	140.15M
Account Payables	2.58M	1.52M	1.98M	1.56M	3.47M	2.45M	2M	3.45M	1.9M
Deferred Revenue	n/a	n/a	n/a	6.96M	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	185K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	30.02M	3.29M	6.43M	5.24M	5.38M	5.28M	4.38M	4.94M	3.52M
Total Current Liabilities	35.4M	6.87M	12.13M	12.29M	13.38M	12.54M	7.9M	9.94M	7.35M
Long-Term Debt	937K	n/a	1.37M	2.6M	1.23M	2.31M	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	-1.37M	-2.6M	-1.23M	-2.31M	869K	971K	1.41M
Total Long-Term Liabilities	937K	n/a	1.37M	2.6M	1.23M	2.31M	869K	971K	1.41M
Total Liabilities	36.34M	6.87M	12.13M	12.29M	13.38M	12.54M	7.9M	9.94M	7.35M
Total Debt	1.12M	1.37M	2.6M	3.65M	2.31M	3.19M	n/a	n/a	n/a
Common Stock	7K	5K	5K	5K	3K	3K	3K	2K	2K
Retained Earnings	-397.01M	-334.72M	-307.69M	-266.38M	-223.14M	-217.15M	-170.47M	-123.53M	-67.87M
Comprehensive Income	-1.29M	-967K	-563K	1.87M	4K	29K	-34K	-41K	-39K
Shareholders Equity	32.57M	38.68M	56.12M	97.16M	72.15M	71.11M	110.34M	84.83M	132.8M
Total Investments	55.76M	30.65M	51.02M	40.26M	65.03M	72.83M	75.4M	44.95M	129.85M